BPC-157 is a synthetic pentadecapeptide (15 amino acids) investigated in preclinical and cellular research across tissue-repair, angiogenesis and gastrointestinal models.

How many amino acids are in BPC-157?

BPC-157 contains 15 amino acids, hence its classification as a pentadecapeptide.

What areas of research involve BPC-157?

Reported research areas include tissue-repair models, angiogenesis-related signalling, gastrointestinal experimental models, tendon/ligament models and nitric-oxide-related pathways.

Is most BPC-157 research preclinical?

Yes. Much of the published BPC-157 literature is drawn from cellular and animal models. Human evidence is comparatively limited.

Is BPC-157 the same as TB-500?

No. BPC-157 and TB-500 are distinct research compounds with different sequences and different research histories.

Is BPC-157 used in PepDirect blends?

Yes. BPC-157 is a component of PepDirect's GLOW, KLOW and Wolverine blends. Evidence for BPC-157 alone does not automatically prove effects for these exact blend formulations.

Is PepDirect BPC-157 intended for human use?

No. PepDirect supplies BPC-157 as a laboratory research product only. It is not marketed as a medicine, food supplement or product for human or veterinary use.

↳ Research overview

What Is BPC-157?

BPC-157 is a synthetic 15-amino-acid peptide (a pentadecapeptide) widely investigated in experimental and preclinical models across tissue-repair, angiogenesis-related signalling and gastrointestinal research.

Much of the published BPC-157 evidence comes from animal and laboratory models. Findings in rodents or cell systems should not automatically be represented as established human benefits.

For laboratory research use only. PepDirect supplies this material in laboratory formats only.

§ Identity

BPC-157 Identity and Research Background

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide (15 amino acids). The sequence was originally derived from a fragment of a gastric-juice protein and has been investigated in laboratory and preclinical research settings for several decades.

§ Research themes

How Is BPC-157 Studied?

Tissue-repair experimental models
Angiogenesis-related signalling
Gastrointestinal experimental models
Tendon and ligament experimental models
Nitric-oxide-related pathway research

The above are described as research areas explored in cellular and animal models. They are not statements of demonstrated clinical outcomes in humans.

§ Evidence

What Does the Evidence Actually Show?

A substantial preclinical / animal literature exists for BPC-157. Direct human evidence is much more limited.

Findings observed in rodents or cell systems cannot automatically be represented as human outcomes. When interpreting BPC-157 research it is essential to distinguish between cell studies, animal models and human clinical evidence.

§ Comparative

BPC-157 and TB-500

BPC-157 and TB-500 are distinct research compounds with different chemical identities, sequences and research histories. They are frequently discussed alongside each other in tissue-repair research but should not be presented as an interchangeable pair or as a human protocol.

§ Blends

BPC-157 in Research Blends

BPC-157 is a component of several PepDirect research blends including GLOW, KLOW and Wolverine. Evidence for BPC-157 alone does not automatically prove the effects of those exact blend formulations, direct research on the specific combined formulation is required for blend-level conclusions.

§ Research product

View the BPC-157 research product

PepDirect supplies BPC-157 as lyophilised research material with lot-specific documentation.

View BPC-157 Research Peptide →

§ References

Selected research references

BPC-157 · PubChem CID 9941957 (pentadecapeptide)PubChem (NCBI)
Pentadecapeptide BPC 157 and the Central Nervous SystemPubMed · Sikiric et al.
Stable Gastric Pentadecapeptide BPC 157, preclinical research reviewPubMed · Sikiric et al.
BPC 157 and Its Effects on Wound Healing and Angiogenesis (preclinical)PubMed · Chang et al.

§ FAQ

Frequently asked questions

What is BPC-157?: BPC-157 is a synthetic pentadecapeptide (15 amino acids) investigated in preclinical and cellular research across tissue-repair, angiogenesis and gastrointestinal models.
How many amino acids are in BPC-157?: BPC-157 contains 15 amino acids, hence its classification as a pentadecapeptide.
What areas of research involve BPC-157?: Reported research areas include tissue-repair models, angiogenesis-related signalling, gastrointestinal experimental models, tendon/ligament models and nitric-oxide-related pathways.
Is most BPC-157 research preclinical?: Yes. Much of the published BPC-157 literature is drawn from cellular and animal models. Human evidence is comparatively limited.
Is BPC-157 the same as TB-500?: No. BPC-157 and TB-500 are distinct research compounds with different sequences and different research histories.
Is BPC-157 used in PepDirect blends?: Yes. BPC-157 is a component of PepDirect's GLOW, KLOW and Wolverine blends. Evidence for BPC-157 alone does not automatically prove effects for these exact blend formulations.
Is PepDirect BPC-157 intended for human use?: No. PepDirect supplies BPC-157 as a laboratory research product only. It is not marketed as a medicine, food supplement or product for human or veterinary use.

§ Related